John B. Sanfilippo & Son (JBSS)
(Delayed Data from NSDQ)
$102.21 USD
-1.58 (-1.52%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $101.93 -0.28 (-0.27%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
JBSS 102.21 -1.58(-1.52%)
Will JBSS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for JBSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JBSS
TreeHouse (THS) to Divest Lakeville Facility & Snack Bars Unit
JBSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for JBSS
Bullish Two Hundred Day Moving Average Cross - JBSS
John B. Sanfilippo & Son, Inc. Declares $1.25 Per Share Special Dividend and a Regular Annual Dividend of $0.85 Per Share
John B. Sanfilippo & Son declares $0.85 dividend & special cash dividend of $1.25/share
Dividend Champion, Contender, And Challenger Highlights: Week Of June 16
John B. Sanfilippo & Son Is Well Run But Overvalued